SG
CELG

StoneX Group’s Celgene Corp CELG Stock Holding History

StoneX Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,805
Closed -$250K – 232
2018
Q1 		$250K Buy
+2,805
New +$269K 0.24% 168
2017
Q4 		– Sell
-1,455
Closed -$212K – 211
2017
Q3 		$212K Sell
1,455
-4,609
-76% -$628K 0.26% 155
2017
Q2 		$788K Buy
+6,064
New +$743K 0.25% 146

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

StoneX Group's CELG Position: Q2 2018 in Review

StoneX Group sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 2,805 shares — an estimated $250K sold.

StoneX Group first reported a position in CELG in Q2 2017 and held it in 3 quarters. The position peaked at $788K in Q2 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • StoneX Group reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • StoneX Group sold 2,805 Celgene Corp shares in Q2 2018, an estimated $250K.
  • StoneX Group first reported a position in Celgene Corp in Q2 2017 and held it in 3 quarters.
  • StoneX Group's Celgene Corp position peaked at $788K in Q2 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on StoneX Group's 13F filing for Q2 2018, filed 23 Jul 2018.